← Evidence map

ArticleArthritis research & therapy2024

Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.

Takumi Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38702742